Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2018-11-07 | 2018-08-24 |
| Drug Identification Number | 02468425 | 02468425 |
| Brand name | SHINGRIX | SHINGRIX |
| Common or Proper name | Herpes Zoster vaccine | Herpes Zoster vaccine |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
| Strength(s) | 50MCG | 50MCG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 10's | 10's |
| ATC code | J07BK | J07BK |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2018-08-24 | 2018-08-24 |
| Estimated end date | 2018-12-31 | 2018-12-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | High demand for the drug coupled with the variable timing of supply shipments. Supply unavailable in the private market. | High demand for the drug coupled with the variable timing of supply shipments. Supply disruptions may be seen in the private market. Product under allocation. |
| Health Canada comments |